Ipsen Announces Decision to Permanently Discontinue Distribution of NutropinAq® (somatropin) cartridges
Ipsen Announces Decision to Permanently Discontinue Distribution of NutropinAq® (somatropin) cartridges
Ipsen Announces Decision to Permanently Discontinue Distribution of NutropinAq® (somatropin) cartridges
- 24 April 2023 - 1 mins read
Ipsen Announces Decision to Permanently Discontinue Distribution of NutropinAq® (somatropin) cartridges
Related Statements
22 June 2023
1 mins read
Ipsen CEO David Loew is elected to EFPIA leadership; joins industry partners to warn of impact of EU pharma legislation
06 June 2023
2 mins read
Ipsen and Medetia join forces to accelerate early research in rare disease
20 February 2023
1 mins read